Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Ascend Phase 3 Study of Acalabrutinib vs Investigator's Choice of Rituximab Plus Idelalisib (IDR) or Bendamustine (BR) in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)
- Authors
- Hebart, Holger; Ghia, Paolo; Jurczak, Wojciech; Pluta, Andrzej; Wach, Malgorzata; Lysak, Daniel; Kozak, Tomas; Simkovic, Martin; Kaplan, Polina; Kryachok, Irina; Illes, Arpad; De la Serna, Javier; Dolan, Sean; Campbell, Philip; Musuraca, Gerardo; Jacob, Abraham; Avery, Eric; Patel, Priti; Quah, Cheng; Liang, Wei; Lee, Jae Hoon
- Issue Date
- Feb-2020
- Publisher
- KARGER
- Citation
- ONCOLOGY RESEARCH AND TREATMENT, v.43, pp.128 - 129
- Journal Title
- ONCOLOGY RESEARCH AND TREATMENT
- Volume
- 43
- Start Page
- 128
- End Page
- 129
- ISSN
- 2296-5270
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Lee, Jae Hoon
- College of Medicine (Department of Medicine)